THIS AMENDED AND RESTATED SALES REPRESENTATIVE AGREEMENT is made as of August 4, 2003 (“Effective Date”), by and between MicroTherapeutics, Incorporated, a Delaware corporation with its principal place of business at 2 Goodyear, Irvine California (“MTI”) and ev3 International, Inc., aDelaware corporation (formerly known as Vertomed International, Inc.) with its principal place of business.
Jennifer.



